| Authors: |
Bauer M; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.; M. Bauer and M. Zeitlinger contributed equally to this article as lead authors and supervised the work., Jorda A; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria., Al-Jalali V; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria., Wölfl-Duchek M; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria., Bergmann F; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria., Nussbaumer-Pröll A; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria., Steindl A; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Gugenberger R; APEIRON Respiratory Therapies GmbH, Vienna, Austria., Bischof S; APEIRON Respiratory Therapies GmbH, Vienna, Austria., Wimmer D; APEIRON Respiratory Therapies GmbH, Vienna, Austria., Idzko M; Department of Pulmonology, Medical University of Vienna, Vienna, Austria., Zeitlinger M; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.; M. Bauer and M. Zeitlinger contributed equally to this article as lead authors and supervised the work. |
